FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625101494> ?p ?o ?g. }

• W2625101494 endingPage "603.e14" @default.
• W2625101494 startingPage "603.e7" @default.
• W2625101494 abstract "The selection of patients with metastatic clear cell renal cell carcinoma (ccRCC) who may benefit from targeted tyrosine kinase inhibitors has been a challenge, even more so now with the advent of new therapies. Hilar fat infiltration (HFI) is a validated prognostic factor in nonmetastatic ccRCC (TNM 2009 staging system) but has never been studied in metastatic patients. We aimed to assess its phenotype and prognostic effect in patients with metastatic ccRCC treated with first-line sunitinib. In a multicentric study, we retrospectively included 90 patients and studied the corresponding ccRCC at the pathological, immunohistochemical, and molecular levels. Patient and tumor characteristics were compared using univariate and multivariate analysis. All the features were then studied by Cox models for prognostic effect. HFI was found in 42 patients (46.7%), who had worse prognosis (Heng criteria) (P = 0.003), liver metastases (P = 0.036), and progressive diseases at first radiological evaluation (P = 0.024). The corresponding ccRCC was associated with poor pathological prognostic factors that are well known in nonmetastatic ccRCC. For these patients, median progression-free survival was 4 months vs. 13 months (P = 0.02), and median overall survival was 14 months vs. 29 months (P = 0.006). In a multivariate Cox model integrating all the variables, only poor prognosis, according to the Heng criteria and HFI, remained independently associated with both progression-free survival and overall survival. HFI was demonstrated for the first time to be an independent poor prognostic factor. Its potential role in predicting resistance to antiangiogenic therapy warrants further investigation." @default.
• W2625101494 created "2017-06-23" @default.
• W2625101494 creator A5004888910 @default.
• W2625101494 creator A5005586319 @default.
• W2625101494 creator A5006462902 @default.
• W2625101494 creator A5021549650 @default.
• W2625101494 creator A5028890871 @default.
• W2625101494 creator A5040427314 @default.
• W2625101494 creator A5040832651 @default.
• W2625101494 creator A5049425103 @default.
• W2625101494 creator A5061266716 @default.
• W2625101494 creator A5061813933 @default.
• W2625101494 creator A5069522018 @default.
• W2625101494 creator A5078599853 @default.
• W2625101494 creator A5081990675 @default.
• W2625101494 creator A5082155887 @default.
• W2625101494 creator A5082534821 @default.
• W2625101494 creator A5086771566 @default.
• W2625101494 creator A5088487307 @default.
• W2625101494 creator A5088899598 @default.
• W2625101494 date "2017-10-01" @default.
• W2625101494 modified "2023-09-30" @default.
• W2625101494 title "Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment" @default.
• W2625101494 cites W1595998158 @default.
• W2625101494 cites W1998668334 @default.
• W2625101494 cites W2019607817 @default.
• W2625101494 cites W2022914202 @default.
• W2625101494 cites W2027442301 @default.
• W2625101494 cites W2050431231 @default.
• W2625101494 cites W2054420426 @default.
• W2625101494 cites W2055229817 @default.
• W2625101494 cites W2062203251 @default.
• W2625101494 cites W2070640824 @default.
• W2625101494 cites W2079613095 @default.
• W2625101494 cites W2099752220 @default.
• W2625101494 cites W2103135030 @default.
• W2625101494 cites W2119770043 @default.
• W2625101494 cites W2119964871 @default.
• W2625101494 cites W2125460987 @default.
• W2625101494 cites W2129407204 @default.
• W2625101494 cites W2130156237 @default.
• W2625101494 cites W2139362036 @default.
• W2625101494 cites W2149456801 @default.
• W2625101494 cites W2153238348 @default.
• W2625101494 cites W2154146769 @default.
• W2625101494 cites W2161472946 @default.
• W2625101494 cites W2165625761 @default.
• W2625101494 cites W2201672580 @default.
• W2625101494 cites W2222086386 @default.
• W2625101494 cites W2278263526 @default.
• W2625101494 cites W2521838781 @default.
• W2625101494 doi "https://doi.org/10.1016/j.urolonc.2017.05.015" @default.
• W2625101494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28619630" @default.
• W2625101494 hasPublicationYear "2017" @default.
• W2625101494 type Work @default.
• W2625101494 sameAs 2625101494 @default.
• W2625101494 citedByCount "0" @default.
• W2625101494 crossrefType "journal-article" @default.
• W2625101494 hasAuthorship W2625101494A5004888910 @default.
• W2625101494 hasAuthorship W2625101494A5005586319 @default.
• W2625101494 hasAuthorship W2625101494A5006462902 @default.
• W2625101494 hasAuthorship W2625101494A5021549650 @default.
• W2625101494 hasAuthorship W2625101494A5028890871 @default.
• W2625101494 hasAuthorship W2625101494A5040427314 @default.
• W2625101494 hasAuthorship W2625101494A5040832651 @default.
• W2625101494 hasAuthorship W2625101494A5049425103 @default.
• W2625101494 hasAuthorship W2625101494A5061266716 @default.
• W2625101494 hasAuthorship W2625101494A5061813933 @default.
• W2625101494 hasAuthorship W2625101494A5069522018 @default.
• W2625101494 hasAuthorship W2625101494A5078599853 @default.
• W2625101494 hasAuthorship W2625101494A5081990675 @default.
• W2625101494 hasAuthorship W2625101494A5082155887 @default.
• W2625101494 hasAuthorship W2625101494A5082534821 @default.
• W2625101494 hasAuthorship W2625101494A5086771566 @default.
• W2625101494 hasAuthorship W2625101494A5088487307 @default.
• W2625101494 hasAuthorship W2625101494A5088899598 @default.
• W2625101494 hasBestOaLocation W26251014942 @default.
• W2625101494 hasConcept C126322002 @default.
• W2625101494 hasConcept C143998085 @default.
• W2625101494 hasConcept C144301174 @default.
• W2625101494 hasConcept C204232928 @default.
• W2625101494 hasConcept C207886595 @default.
• W2625101494 hasConcept C2777472916 @default.
• W2625101494 hasConcept C2778019345 @default.
• W2625101494 hasConcept C2778560582 @default.
• W2625101494 hasConcept C2778695046 @default.
• W2625101494 hasConcept C2779490328 @default.
• W2625101494 hasConcept C2781278892 @default.
• W2625101494 hasConcept C38180746 @default.
• W2625101494 hasConcept C50382708 @default.
• W2625101494 hasConcept C71924100 @default.
• W2625101494 hasConceptScore W2625101494C126322002 @default.
• W2625101494 hasConceptScore W2625101494C143998085 @default.
• W2625101494 hasConceptScore W2625101494C144301174 @default.
• W2625101494 hasConceptScore W2625101494C204232928 @default.
• W2625101494 hasConceptScore W2625101494C207886595 @default.
• W2625101494 hasConceptScore W2625101494C2777472916 @default.
• W2625101494 hasConceptScore W2625101494C2778019345 @default.

• next